Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoer Chaiqin Qingjie is a traditional Chinese medicine (TCM) formulation, typically available as granules, used primarily in pediatric populations. It is indicated for the treatment of tic disorders in children and may have applications in other pediatric conditions involving heat-clearing and detoxification according to TCM principles. The exact composition is not fully detailed in available English-language sources, but it belongs to a class of multi-herb TCM formulas designed to clear heat and resolve stagnation[2][9]. The mechanism of action is not fully elucidated but likely involves modulation of inflammatory pathways and neurotransmitter regulation based on its use for tic disorders[2][3]. There are ongoing clinical trials evaluating its efficacy and safety for these indications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiaoer chaiqin qingjie.